Premium
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2 V617F allele burden correlates
Author(s) -
Gangat Naseema,
Strand Jacob,
Lasho Terra L.,
Finke Christy M.,
Knudson Ryan A.,
Pardanani Animesh,
Li ChinYang,
Ketterling Rhett P.,
Tefferi Ayalew
Publication year - 2008
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.2007.01003.x
Subject(s) - polycythemia vera , jak2 v617f , medicine , allele , gastroenterology , genetics , myelofibrosis , biology , gene , bone marrow
The prognostic significance of cytogenetic findings at diagnosis in polycythemia vera (PV) was investigated in a retrospective series of 137 patients. Cytogenetics were normal in 117 patients (85%) and displayed a −Y abnormality in five patients (7% of male patients), and other chromosomal abnormalities in 15 patients (11%). The most frequent cytogenetic anomalies were trisomy 8 ( n = 4), trisomy 9 ( n = 2), deletion 20q ( n = 2) and chromosomal 1 abnormalities ( n = 2). Parameters that were significantly associated with abnormal cytogenetics included age ≥60 yr ( P = 0.02), but not JAK2 V617F allele burden, thrombosis, hemorrhage, leukemic/fibrotic transformation, or survival. We conclude that cytogenetic anomalies occur infrequently at PV diagnosis and do not confer an adverse outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom